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ABSTRACT 
Background: Pseudomonas aeruginosa is a known opportunistic pathogen frequently causing serious 
infections. It exhibits innate resistance to a wide range of antibiotics thus causing high rates of morbidity 
and mortality worldwide.                                                                                                                             
Objective: This study was done to determine the distribution and the antibiotic susceptibility pattern in 
clinical isolates of Pseudomonas aeruginosa in NHA.                                                                                        
Method: Laboratory data on 265 Pseudomonas aeruginosa isolates from a total of 30,384 clinical specimens 
processed over a 3 year period (January 1st 2010 to December 31st 2012) were analyzed.                                         
Results: A total 30,384 samples were submitted for bacteriologic analysis, 265 (1%) yielded Pseudomonas 
aeruginosa of which 195 (74%) were from in-patient sand 70 (26%) fromout-patients.185 (70%) isolates were 
from adults while 80 (30%) were from children. 87% of the isolates were susceptible to imipenem, 77% to 
amikacin, while 34% were resistant to ciprofloxacin and 46% resistant to ceftazidime.                                
Conclusion: The relatively high proportion of resistance to ciprofloxacin and ceftazidime, and the 
emerging resistance to amikacin and imipenem are worrisome and calls for rational antibiotic use and 
institution of effective resistance surveillance and infection control measures. . 
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RESUME 
Contexte: Pseudomonas aeroginosa est un germe pathogène opportuniste reconnu causant fréquemment 
des sérieuses infections. Il présente à la résistance innée à une large gamme d’antibiotiques provoquant de 
taux  élevés de morbidité et de mortalité dans le monde.                                                                                             
Objectif: Cette étude a été réalisée pour déterminer la répartition et la sensibilité d’antibiotiques de 
souches cliniques de Pseudomonas aeriginosa à l’hôpital National d’Abuja.                                                          
Méthodes: Les données de laboratoire de 265 souches de Pseudomonas aeriginosae isolées à partir de 30 384 
d’échantillons cliniques traités sur une période de 3 ans (1er Janvier 2010 au 31 Décembre 2012) ont été 
analysées.                                                                                                                                                                             
Résultats: Au total, 30 384 échantillons ont été soumis pour l’analyse bactériologique: Pseudomonas 
aeriginosa ont été obtenus dans 265 (1%) échantillons dont 195 (74%) étaient des patients hospitalisés et 70 
(26%) patients externes. 185 (70%) souches ont été isolées chez les adultes alors que 80 (30%) étaient chez les 
enfants. 87% de souches étaient sensibles à l’imipenème, 77% à l’amikacine, pendant que 34% étaient 
résistantes à la ciprofloxacine et 46% à la ceftazidime.                                                                     
Conclusion: La proportion relativement élevée de la résistance à la ciprofloxacine et à la ceftazidime, et 
l’émergence d’une résistance à l’amikacine et à l’imipenème est inquiétante, et les appels à usage rationnel 
de l'antibiotique et une institution de surveillance efficace de la résistance et les mesures du contrôle de 
l'infection. 
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Pseudomonas aeruginosa is a Gram-negative aerobic 
rod that causes severe nosocomial infections, 
associated with increased mortality (1,2). It has a 
predilection for moist environments and can be 
found in water and soil and on plants, including 
fruits, vegetables, and flowers (3).  
The organism is rarely found as part of the 
microbial flora of healthy people, but may 
occasionally colonize healthy individuals; the sites 
of colonization include the gastrointestinal tract 
and moist body sites, such as the throat, nasal 
mucosa, axillary skin and perineum (3). Aqueous 
solutions used in medical care such as 
disinfectants, soaps, irrigation fluids, eye drops, 
and dialysis fluids may all become contaminated 
with P. aeruginosa (4).  
Nosocomial infections caused by P. aeruginosa 
have been recognized as an acute problem in 
hospitals due to its intrinsic resistance to many 
classes of antibiotics and its ability to acquire 
resistance to all effective antibiotics (5). These 
infections among others include surgical site 
infections, urinary tract infections, pneumonia, 
and bloodstream infections (BSI) (6). 
Effective management of P. aeruginosa infections 
requires good background knowledge of the 
prevailing antimicrobial susceptibility patterns of 
the organism. There is paucity of data on 
Pseudomonas aeruginosa infections in Abuja. This 
study was therefore, carried out to determine the 
distribution and the antibiotic susceptibility 
pattern of Pseudomonas aeruginosa in clinical 
isolates at the National Hospital Abuja, to serve as 
a guide for doctors managing patients with 
Pseudomonas aeruginosa infections. 
METHOD 
The data studied were from the archival records of 
the department of medical microbiology of 
National Hospital Abuja, a 200-bedded referral 
tertiary hospital located in the heart of the Federal 
Capital Territory of Nigeria, over a three-year 
period stretching from 1st January 2010 to 31st 
December 2012. 
Records of Pseudomonas aeruginosa isolates were 
analyzed for gender, age, ward, sample type and 
antibiotic susceptibility using Microsoft excel 2007 
software. Isolates with no age, gender, ward and 
antibiotic susceptibility were excluded (N= 42). 
All samples were processed and identifications 
carried out using established procedures7.  
RESULTS 
A total 30,384 samples were submitted for 
bacteriologic analysis, 265(1%) yielded 
Pseudomonas aeruginosa. Of these185 (70%) were 
from adults, while80 (30%) were from children.140 
(53%) were males while 125 (47%) were females 
(Table 1). 
TABLE 1: AGE AND GENDER DISTRIBUTION OF 
PATIENTS WITH PSEUDOMONAS AERUGINOSA 
ISOLATES 
 
195(74%) isolates were from in-patients and 
70(26%) from out-patients. Surgery & paediatrics 
had higher isolates from the inpatient 
wards,61(31%)and 49(25%) respectively, while the 
intensive care unit (ICU) and the accident and 
emergency (A&E) unit specimens respectively 
yielded 9(5%) and 26(14%) of the isolates (Table 2). 
Pseudomonas aeruginosa  was sensitive to imipenem 
87%(176/203), amikacin 77%(142/185),but  
resistant to ciprofloxacin 34%(59/175), gentamicin 
44%(70/160), ofloxacin45%(29/64) and 
ceftazidime 46%(85/191).(Table 3).  Resistance in 







AGE n % 
Neonate (<28days) 16 6.0 
Infants (>29days -1yr) 29 11.0 
Children(>1 -15yrs) 35 13.2 
Adult (>15 – 64yrs) 167 63.0 
Elderly (>65yrs) 18 6.8 
TOTAL 265 100 
 
GENDER N % 
Male  140 52.8 
Female 125 47.2 
Total    265  100 
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TABLE 2; PSEUDOMONAS AERUGINOSA 
ISOLATES IN SELECTED LOCATIONS 





          Medical 37 20 
          Surgical 61 32 
          Gynaecology 13 7 
           ICU 9 5 
        A &E 26 14 
         Paediatrics 49 25 
Total In-patients 195 74 
Grand Total 265 100 
 
 
TABLE 3: SENSITIVITY PATTERN OF 
PSEUDOMONAS AERUGINOSA 
Antibiotics No tested  % Sensitivity 
Imipenem 176 (203) 87 
Amikacin 142 (185) 77 
Ciprofloxacin 116 (175) 66 
Gentamicin 90 (160) 56 
Ofloxacin 35 (64) 55 
Ceftazidime 106(191) 56 
 
TABLE 4. PERCENTAGE SENSITIVITY OF PSEUDOMONAS ISOLATES BY LOCATION 
 
    Wards 
 
Antibiotics  
Surgical  Medical  ICU Paediatric A& E Gynae Outpatient 
Imipenem 93 (42/45) 90 (18/20) 83 (5/6) 88 (28/32) 80 (12/15) 71(5/7) 89(41/46) 
Amikacin 82 (37/45) 77 (17/22) 66.7  (2/3) 81 (17/21) 71   
(10/14) 
71 (5/7) 78(28/36) 
Ciprofloxacin  69 (29/42) 26 (5/19) 43 (3/7) 88 (21/24) 79  (11/14) 83    (5/6) 63(22/35) 
Gentamicin 63 (27/43) 50 (10/20) 50  (1/2) 69 (16/23) 46 (6/13) 100   (4/4) 55  (16/29) 
Ofloxacin 42 (5/12) 100 (3/3) 100  (1/1) 83(10/12) 57 (4/7) 43    (3/7) 38 (5/13) 
Ceftazidime 72 (28/39) 24(5/21) 25  (1/4) 54  (19/35) 47 (7/15) 60  (3/5) 67   (28/42) 
 
DISCUSSION 
This study revealed that Pseudomonas aeruginosa 
infections were more common in adults than in 
children, but higher in children fifteen years and 
below than in the elderly; there is a slight male 
preponderance. These results agree with those of  
 
similar studies carried out in Enugu, Nigeria and 
India (8,9).Surgery ward had the highest number 
of isolates. This may be because surgical patients 
stay relatively long in the hospital, have a breach 
of their protective skin and the fact that many 
patients going in for major surgery tend to get 
catheterised. 
The high resistance profile of the isolates to 
ciprofloxacin and ceftazidime most probably 
reflects the extensive and inappropriate use of 
these antibiotics as revealed in previous studies 
(9,10).  The resistance to ceftazidime is particularly 
worrisome as this is the only third generation  
 
 
cephalosporin to which Pseudomonas aeruginosa 
is naturally sensitive. The relatively and moderate 
sensitivity to imipenem and amikacin again 
mirrors the not too frequent use of these drugs in 
our facility. With increasing resistance to 
ceftazidime and ciprofloxacin there is tendency 
that more selective pressure will bear on these 
drugs as therapeutic alternatives, with rising 
resistance. The pattern of antibiotic sensitivity may 
vary in different hospitals, and in different 
sections of the same hospital depending on such 
factors such as antibiotic prescribing policy, types 
of patients, level of hygiene and infections control 
practices.  
The sensitivity pattern seen in this study shows 
that inappropriate antibiotic treatment for 
Pseudomonas aeruginosa infections, and indeed 
other infections, may lead to increased morbidity 
and mortality in the hospital. There is therefore, 
need to maintain regular antibiotic surveillance 
and to adhere to rational antibiotic prescribing 
guidelines.
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